Christopher Mutz Ani Pharmaceuticals Inc (ANIP) insider trading activity
Christopher Mutz is HEAD OF RARE DISEASE of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 111,317 shares of ANIP, which is worth approximately $6.96 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 2,874 shares (Common Stock) at a price of $60.62 per share, resulting in proceeds of $174,221. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
111K
44.99%
3M change
30.54%
12M change
Total Value Held
$6.96 Million
Christopher Mutz Transaction History
CM
Christopher Mutz
HEAD OF RARE DISEASE
Baudette, MN